BIAF
bioAffinity·NASDAQ
--
--(--)
--
--(--)
3.75 / 10
Netural
Fund flow metrics score 7.51/10, revealing robust fund flow characteristics. Beneficial Small and Large trends are challenged by problematic overall, block, Medium, and Extra-large signals, indicating positive capital movement. Analyst sentiment reflects divided analyst consensus with neutral perspective. The rating profile includes Neutral(100.0%) from 1 analytical reports, supported by 0.00 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-04-01
InstitutionMaxim Group
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for BIAF?
- BIAF holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.75/10 (Netural).
